BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16584615)

  • 1. [Biological activities of the coagulation factor VIII, IX in platelet concentrates collected by platelet apheresis during preservation].
    Yang JC; Li FQ; Li MH; Ren JK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):162-4. PubMed ID: 16584615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of preanalytical frozen storage time and temperature on screening coagulation tests and factors VIII and IX activity.
    Zhao Y; Feng G; Zhang J; Gong R; Cai C; Feng L
    Sci Rep; 2017 Sep; 7(1):12179. PubMed ID: 28939816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of residual platelet count on routine coagulation, factor VIII, and factor IX testing in postfreeze-thaw samples.
    Lippi G; Rossi R; Ippolito L; Zobbi V; Azzi D; Pipitone S; Favaloro EJ; Funk DM
    Semin Thromb Hemost; 2013 Oct; 39(7):834-9. PubMed ID: 24022807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation factor activity in platelet concentrates.
    Simon TL; Henderson R
    Transfusion; 1979; 19(2):186-9. PubMed ID: 432931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor IX ectopically expressed in platelets can be stored in alpha-granules and corrects the phenotype of hemophilia B mice.
    Zhang G; Shi Q; Fahs SA; Kuether EL; Walsh CE; Montgomery RR
    Blood; 2010 Aug; 116(8):1235-43. PubMed ID: 20445020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of apheresis platelet concentrates stored for 5 days in PL 732 bags.
    Kiraly TR; Kalish RI; Norton DF
    J Clin Apher; 1987; 3(3):178-80. PubMed ID: 3558343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, storage and quality control of platelet concentrates.
    Tynngård N
    Transfus Apher Sci; 2009 Oct; 41(2):97-104. PubMed ID: 19699153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical comparison of platelet preparation methods.
    Vassallo RR; Murphy S
    Curr Opin Hematol; 2006 Sep; 13(5):323-30. PubMed ID: 16888436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of platelet concentrates derived by platelet rich plasma, buffy coat and Apheresis.
    Vasconcelos E; Figueiredo AC; Seghatchian J
    Transfus Apher Sci; 2003 Aug; 29(1):13-6. PubMed ID: 12877887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 24-hour shelf-life of cytapheresis platelet concentrates stored in polyvinyl chloride containers should be extended only with caution.
    Strauss RG; Snyder EL; Eckermann I; Stewart L
    Transfusion; 1987; 27(3):284-7. PubMed ID: 3590294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo evaluation of apheresis platelets stored for 5 days in 65% platelet additive solution/35% plasma.
    Vassallo RR; Adamson JW; Gottschall JL; Snyder EL; Lee W; Houghton J; Elfath MD
    Transfusion; 2010 Nov; 50(11):2376-85. PubMed ID: 20497516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days.
    Shanwell A; Diedrich B; Falker C; Jansson B; Sandgren P; Sundkvist L; Svensson L; Vesterinen M; Gulliksson H
    Transfusion; 2006 Jun; 46(6):973-9. PubMed ID: 16734814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collection, storage, inspection and quality control of platelet concentrates obtained by apheresis: The situation in Spain.
    Castrillo A; Jimenez-Marco T; Arroyo JL; Jurado ML; Larrea L; Maymo RM; Monge J; Muñoz C; Pajares Á; Yáñez M;
    Transfus Apher Sci; 2017 Jun; 56(3):357-361. PubMed ID: 28319015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Freeze-Thaw Times on Screening Coagulation Tests and Factors VIII and IX Activities in Citrate-Anticoagulated Plasma at -20°C and -80°C.
    Feng G; Zhao Y; Zhang J; Feng L
    Clin Lab; 2018 Sep; 64(9):1439-1444. PubMed ID: 30274007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of factor VIII and factor IX in fresh-frozen plasma produced from whole blood stored at 4 °C overnight in Turkey.
    Agus N; Yilmaz N; Colak A; Liv F
    Blood Transfus; 2012 Apr; 10(2):191-3. PubMed ID: 22153689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet activation of platelet concentrates derived from buffy coat and apheresis methods.
    Ali SF
    Transfus Apher Sci; 2011 Feb; 44(1):11-3. PubMed ID: 21277261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of delayed blood processing on the yield of factor VIII in cryoprecipitate and factor VIII concentrate.
    Hughes C; Thomas KB; Schiff P; Herrington RW; Polacsek EE; McGrath KM
    Transfusion; 1988; 28(6):566-70. PubMed ID: 3143170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of coated platelet potential during collection, storage, and transfusion of apheresis platelets.
    Charania R; Smith J; Vesely SK; Dale GL; Holter J
    Transfusion; 2011 Dec; 51(12):2690-4. PubMed ID: 21645004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factor release from platelet concentrates: analytic quantification and characterization for clinical applications.
    Durante C; Agostini F; Abbruzzese L; Toffola RT; Zanolin S; Suine C; Mazzucato M
    Vox Sang; 2013 Aug; 105(2):129-36. PubMed ID: 23639058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of store lesion in platelet obtained by apheresis compared to platelet derived from whole blood and its impact on the in vitro functionality.
    Quintero M; Núñez M; Mellado S; Maldonado M; Wehinger S
    Transfus Apher Sci; 2015 Dec; 53(3):293-9. PubMed ID: 26043812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.